Insider Trading & Ownership of Andrew Gengos

Location: Bothell, WA
Summary: The estimated net worth of Andrew Gengos is at least $4,291,710 dollars as of 16 Jan 2026. Andrew Gengos is the Chief Financial Officer of Terns Pharmaceuticals, Inc. and owns shares of Terns Pharmaceuticals, Inc. (TERN) stock worth about $4.11M. Andrew Gengos is the Chief Business Officer of Cyteir Therapeutics, Inc. and owns shares of Cyteir Therapeutics, Inc. stock worth about $124.3K. Andrew Gengos is the CFO and Chief Business Officer of Athira Pharma, Inc. and owns shares of Athira Pharma, Inc. (ATHA) stock worth about $55.2K.
Signature: /s/ David Strauss, as Attorney-in-Fact for Andrew Gengos
All Insider Reports: All Insider Reports

Notify me when Andrew Gengos files a new Insider Trading report.

Ownership of Andrew Gengos

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
TERN	Terns Pharmaceuticals, Inc.	Chief Financial Officer	$4,112,235	+$96,366	+2.4%	14 Jan 2026
CYT	Cyteir Therapeutics, Inc.	Chief Business Officer	$124,272			22 Feb 2022
ATHA	Athira Pharma, Inc.	CFO and Chief Business Officer	$55,203			03 Sep 2024
TTRX	Global Health Solutions, Inc	Director				08 Oct 2025

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.